Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil

Oncology Reports

Volumn 12, Issue 1, 2004, Pages 187-192

  Haveman, J ^a   Castro Kreder, N ^a   Rodermond, H M ^a   Van Bree, C ^a   Franken, N A P ^a   Stalpers, L J A ^a   Zdzienicka, M Z ^b,d   Peters, G J ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

5 fluorouracil; Cisplatin; Gemcitabine; Hamster mutant cell line

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CISPLATIN; DEOXYCYTIDINE; DNA; DRUG DERIVATIVE; FLUOROURACIL; GEMCITABINE;

ANIMAL; ARTICLE; CELL DIVISION; CELL LINE; CHO CELL; DNA REPAIR; DOSE RESPONSE; DRUG EFFECT; GENETICS; HAMSTER; RADIATION EXPOSURE; X RAY;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL DIVISION; CELL LINE; CHO CELLS; CISPLATIN; CRICETINAE; DEOXYCYTIDINE; DNA; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROURACIL; X-RAYS;

EID: 13844295602     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.1.187     Document Type: Article

References (41)

1. Zdzienicka MZ: Mammalian X-ray-sensitive mutants which are defective in non-homologous (illegitimate) DNA double-strand break repair. Biochimie 81: 107-116, 1999.
2. Thacker J and Zdzienicka MZ: The mammalian XRCC genes: their roles in DNA repair and genetic stability. Mutat Res 2: 655-672, 2003. (Pubitemid 36588757)
3. Dewey WC, Furman SC and Miller HH: Comparison of lethality and chromosomal damage induced by x-rays in synchronized Chinese hamster cells in vitro. Radiat Res 43: 561-581, 1970.
4. Karran P: DNA double-strand break repair in mammalian cells. Curr Opin Genet Dev 10: 144-150, 2000.
5. Van Gent DC, Hoeijmakers JH and Kanaar R: Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2: 196-206, 2001. (Pubitemid 33674018)
6. Zdzienicka MZ: Mammalian X-ray sensitive mutants: a tool for the elucidation of the cellular response to ionizing radiation. Cancer Surv 28: 281-293, 1996.
7. Thacker J: The role of homologous recombination processes in the repair of severe forms of DNA damage in mammalian cells. Biochimie 81: 77-85, 1999.
8. Kraakman-van der Zwet M, Overkamp WJ, van Lange RE, Essers J, Duijn-Goedhart A, Wiggers I, Swaminathan S, van Buul PP, Errami A, Tan RT, Jaspers NG, Sharan SK, Kanaar R and Zdzienicka MZ: Brca2 (XRCC11) deficiency results in radio-resistant DNA synthesis and a higher frequency of spontaneous deletions. Mol Cell Biol 22: 669-679, 2002. (Pubitemid 34027510)
9. Hertel LW, Boder GB, Kroin JS, Rinzel SM, Poore GA, Todd GC and Grindey GB: Evaluation of the antitumor activity of gemcitabine (2′,2′- difluoro-2′-deoxycytidine). Cancer Res 50: 4417-4422, 1990. (Pubitemid 20225688)
10. Van Moorsel CJ, Peters GJ and Pinedo HM: Gemcitabine: future prospects of single-agent and combination studies. Oncologist 2: 127-134, 1997. (Pubitemid 27263944)
11. Huang P, Chubb S, Hertel LW, Grindey GB and Plunkett W: Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res 51: 6110-6117, 1991.
12. Heinemann V, Hertel LW, Grindey GB and Plunkett W: Comparison of the cellular pharmacokinetics and toxicity of 2′,2′- difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. Cancer Res 48: 4024-4031, 1988.
13. Rockwell S and Grindey GB: Effect of 2′,2′-difluorodeoxy- cytidine on the viability and radiosensitivity of EMT6 cells in vitro. Oncol Res 4: 151-155, 1992. (Pubitemid 23167108)
14. Shewach DS, Hahn TM, Chang E, Hertel LW and Lawrence TS: Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res 54: 3218-3223, 1994.
15. Latz D, Fleckenstein K, Eble M, Blatter J, Wannenmacher M and Weber KJ: Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′- deoxycytidine) within the cell cycle in vitro. Int J Radiat Oncol Biol Phys 41: 875-882, 1998. (Pubitemid 28285968)
16. Lawrence TS, Chang EY, Hahn TM, Hertel LW and Shewach DS: Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro- 2′-deoxycytidine. Int J Radiat Oncol Biol Phys 34: 867-872, 1996.
17. Rosier JF, Beauduin M, Bruniaux M, De Bast M, De Coster B, Octave-Prignot M, Scalliet P and Gregoire V: The effect of 2′-2′ difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity. Int J Radiat Biol 75: 245-251, 1999. (Pubitemid 29089164)
18. Van Putten JWG, Groen HJM, Smid K, Peters GJ and Kampinga HH: End-joining deficiency and radiosensitization induced by gemcitabine. Cancer Res 61: 1585-1591, 2001. (Pubitemid 34292591)
19. Wachters FM, van Putten JW, Maring JG, Zdzienicka MZ, Groen HJ and Kampinga HH: Selective targeting of homologous DNA recombination repair by gemcitabine. Int J Radiat Oncol Biol Phys 57: 553-562, 2003. (Pubitemid 37040953)
20. Robinson BW, Im MM, Ljungman M, Praz F and Shewach DS: Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells. Cancer Res 63: 6935-6941, 2003. (Pubitemid 37322979)
21. Sundquist WI and Lippard SJ: The coordination chemistry of platinum anticancer drugs and related-compounds with DNA. Coordination Chem Rev 100: 293-322, 1990.
22. Terheggen PM, Emondt JY, Floot BG, Dijkman R, Schrier PI, den Engelse L and Begg AC: Correlation between cell killing by cis- diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum. Cancer Res 50: 3556-3561, 1990. (Pubitemid 20194095)
23. Lawrence TS, Blackstock AW and McGinn C: The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 13: 13-21, 2003. (Pubitemid 36173256)
24. Damia G, Imperatori L, Stefanini M and D'Incalci M: Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents. Int J Cancer 66: 779-783, 1996. (Pubitemid 26197946)
25. De Silva IU, McHugh PJ, Clingen PH and Hartley JA: Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin. Nucleic Acids Res 30: 3848-3856, 2002. (Pubitemid 35012457)
26. Caldecott K and Jeggo P: Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents. Mutat Res 255: 111-121, 1999.
27. Britten RA, Evans AJ, Allalunis-Turner MJ and Pearcey RG: Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines. Int J Radiat Oncol Biol Phys 34: 367-374, 1996. (Pubitemid 26031581)
28. Geldof AA, Kruit A, Newling DW and Slotman BJ: Synergism between cisplatin and radiotherapy in an in vitro prostate tumor cell line. Anticancer Res 19: 505-508, 1999. (Pubitemid 29168284)
29. Douple EB and Richmond RC: Platinum complexes as radio-sensitizers of hypoxic mammalian cells. Br J Cancer Suppl 37: 98-102, 1978. (Pubitemid 8364461)
30. Myint WK, Ng C and Raaphorst GP: Examining the non-homologous repair process following cisplatin and radiation treatments. Int J Radiat Biol 78: 417-424, 2002. (Pubitemid 34496892)
31. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 345: 939-944, 1995.
32. Longley DB, Harkin DP and Johnston PG: 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3: 330-338, 2003. (Pubitemid 37328853)
33. Fuller LF and Painter RB: A Chinese hamster ovary cell line hypersensitive to ionizing radiation and deficient in repair replication. Mutat Res 193: 109-121, 1988. (Pubitemid 18062212)
34. Errami A, He DM, Friedl AA, Overkamp WJ, Morolli B, Hendrickson EA, Eckardt-Schupp F, Oshimura M, Lohman PH, Jackson SP and Zdzienicka MZ: XR-C1, a new CHO cell mutant which is defective in DNA-PKcs, is impaired in both V(D)J coding and signal joint formation. Nucleic Acids Res 26: 3146-3153, 1998. (Pubitemid 28288911)
35. Zdzienicka MZ, van Wessel N and van der Schans GP: A fourth complementation group among ionizing radiation-sensitive Chinese hamster cell mutants defective in DNA double-strand break repair. Radiat Res 131: 309-314, 1992.
36. Zdzienicka MZ, Tran Q, van der Schans GP and Simons JW: Characterization of an X-ray-hypersensitive mutant of V79 Chinese hamster cells. Mutat Res 194: 239-249, 1988. (Pubitemid 18261165)
37. Zdzienicka MZ, van der Schans GP, Natarajan AT, Thompson LH, Neuteboom I and Simons JW: A Chinese hamster ovary cell mutant (EM-C11) with sensitivity to simple alkylating agents and a very high level of sister chromatid exchanges. Mutagenesis 7: 265-269, 1992.
38. Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A and Takeda S: Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J 17: 5497-5508, 1998. (Pubitemid 28427063)
39. Crul M, van Waardenburg RC, Bocxe S, van Eijndhoven MA, Pluim D, Beijnen JH and Schellens JH: DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin. Biochem Pharmacol 65: 275-282, 2003. (Pubitemid 36015830)
40. Zdzienicka MZ, Jaspers NG, van der Schans GP, Natarajan AT and Simons JW: Ataxia-telangiectasia-like Chinese hamster V79 cell mutants with radioresistant DNA synthesis, chromosomal instability, and normal DNA strand break repair. Cancer Res 49: 1481-1485, 1989. (Pubitemid 19088686)
41. Castro Kreder N, ten Cate R, Rodermond HM, van Bree C, Franken NAP, Zdzienicka MZ, Haveman J: Cellular response to pulsed low dose rate irradiation in X-ray sensitive hamster mutant cell lines. J Radiat Res (In press).